Abstract
TCT-40 Medication Use and 3-Year Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings From Real-World Claims Data
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jacc.2021.09.890
Copy DOIPublication Date: Nov 1, 2021 | |
Citations: 1 | License type: publisher-specific-oa |
TCT-40 Medication Use and 3-Year Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings From Real-World Claims Data
Join us for a 30 min session where you can share your feedback and ask us any queries you have